Lolis E - Search Results

1

A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells.

Winner M, Meier J, Zierow S, Rendon BE, Crichlow GV, Riggs R, Bucala R, Leng L, Smith N, Lolis E, Trent JO, Mitchell RA. Winner M, et al. Among authors: lolis e. Cancer Res. 2008 Sep 15;68(18):7253-7. doi: 10.1158/0008-5472.CAN-07-6227. Cancer Res. 2008. PMID: 18794110 Free PMC article.

2

Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor.

Sun HW, Bernhagen J, Bucala R, Lolis E. Sun HW, et al. Among authors: lolis e. Proc Natl Acad Sci U S A. 1996 May 28;93(11):5191-6. doi: 10.1073/pnas.93.11.5191. Proc Natl Acad Sci U S A. 1996. PMID: 8643551 Free PMC article.

3

The subunit structure of human macrophage migration inhibitory factor: evidence for a trimer.

Sun HW, Swope M, Cinquina C, Bedarkar S, Bernhagen J, Bucala R, Lolis E. Sun HW, et al. Among authors: lolis e. Protein Eng. 1996 Aug;9(8):631-5. doi: 10.1093/protein/9.8.631. Protein Eng. 1996. PMID: 8875640

4

Crystal structure of macrophage migration inhibitory factor (MIF), a glucocorticoid-induced regulator of cytokine production, reveals a unique architecture.

Lolis E, Bucala R. Lolis E, et al. Proc Assoc Am Physicians. 1996 Nov;108(6):415-9. Proc Assoc Am Physicians. 1996. PMID: 8956364 Review.

5

The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents.

Lubetsky JB, Dios A, Han J, Aljabari B, Ruzsicska B, Mitchell R, Lolis E, Al-Abed Y. Lubetsky JB, et al. Among authors: lolis e. J Biol Chem. 2002 Jul 12;277(28):24976-82. doi: 10.1074/jbc.M203220200. Epub 2002 May 7. J Biol Chem. 2002. PMID: 11997397 Free article.

6

Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity.

Dios A, Mitchell RA, Aljabari B, Lubetsky J, O'Connor K, Liao H, Senter PD, Manogue KR, Lolis E, Metz C, Bucala R, Callaway DJ, Al-Abed Y. Dios A, et al. Among authors: lolis e. J Med Chem. 2002 Jun 6;45(12):2410-6. doi: 10.1021/jm010534q. J Med Chem. 2002. PMID: 12036350

7

Macrophage migration inhibitory factor.

Lolis E, Bucala R. Lolis E, et al. Expert Opin Ther Targets. 2003 Apr;7(2):153-64. doi: 10.1517/14728222.7.2.153. Expert Opin Ther Targets. 2003. PMID: 12667094 Review.

8

Therapeutic approaches to innate immunity: severe sepsis and septic shock.

Lolis E, Bucala R. Lolis E, et al. Nat Rev Drug Discov. 2003 Aug;2(8):635-45. doi: 10.1038/nrd1153. Nat Rev Drug Discov. 2003. PMID: 12904813 Review. No abstract available.

9

Macrophage migration inhibitory factor promotes intestinal tumorigenesis.

Wilson JM, Coletta PL, Cuthbert RJ, Scott N, MacLennan K, Hawcroft G, Leng L, Lubetsky JB, Jin KK, Lolis E, Medina F, Brieva JA, Poulsom R, Markham AF, Bucala R, Hull MA. Wilson JM, et al. Among authors: lolis e. Gastroenterology. 2005 Nov;129(5):1485-503. doi: 10.1053/j.gastro.2005.07.061. Gastroenterology. 2005. PMID: 16285950

10

Macrophage migration inhibitory factor: a critical component of autoimmune inflammatory diseases.

Bucala R, Lolis E. Bucala R, et al. Among authors: lolis e. Drug News Perspect. 2005 Sep;18(7):417-26. doi: 10.1358/dnp.2005.18.7.939345. Drug News Perspect. 2005. PMID: 16362080 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters